http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110787170-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
filingDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110787170-B |
titleOfInvention | Medicine for treating influenza virus infection |
abstract | The invention relates to a medicament for treating influenza virus infection. Specifically, the invention provides a compound, or an isomer thereof, or a pharmaceutically acceptable salt thereof, wherein the compound has a structure shown in the formula I. The compound, or the isomer thereof, or the pharmaceutically acceptable salt thereof has a remarkable inhibitory effect on influenza virus, and is used for preventing and/or treating influenza virus infection. |
priorityDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 407.